Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The …
Over the last 12 months, insiders at Fortrea Holdings Inc. have bought $0 and sold $0 worth of Fortrea Holdings Inc. stock.
On average, over the past 5 years, insiders at Fortrea Holdings Inc. have bought $504,640 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $504,640 was made by Pike Thomas (Chief Executive Officer) on 2023‑08‑23.
2023-08-23 | Chief Executive Officer | 20,000 0.0267% | $25.23 | $504,640 | +16.84% |
Pike Thomas | Chief Executive Officer | 20000 0.0223% | $18.78 | 1 | 0 | +16.84% |